Epsilon M&A Deal Report - IBL International
Transaction Multiples for the Valuation of Private Companies
Tecan Group / IBL International
No EMAT :
66497
Announced Date :
30/07/2014
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Tecan Group
Target :
IBL International
Country :
Germany
Sector of activity :
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Medical Diagnostic Laboratory
Business Description :
Founded in 1983, IBL International GmbH develops, manufactures, and distributes immunoassays and antibodies/in-vitro diagnostic assays that include enzyme, radio, and luminescence immunoassays for...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
|
|
||
| Current |
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Medical Diagnostic Laboratory » = 55
| Date | Acquirer | Target | Country | Multiples | See details |
| 25/09/2012 | Vetoquinol | Orsco Laboratoire Vétérinaire (OLV) | France | ** | 66308 |
| 30/04/2014 | ANIMEDICA Group | Industria Italiana Integratori Trei | Italy | * | 66260 |
Source: Epsilon Research / EMAT
